Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 13/20 | 0.42 |
| ▸ | CDC25B | P30305 | 8/20 | 0.42 |
| ▸ | PTPN2 | P17706 | 6/20 | 0.41 |
| ▸ | PTPN11 | Q06124 | 5/20 | 0.41 |
| ▸ | PTPN6 | P29350 | 4/20 | 0.41 |
| ▸ | TACR1 | P25103 | 1/20 | 0.38 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.38 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.38 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.38 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.38 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.38 |
| ▸ | TACR2 | P21452 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9356955 | 0.94 | NT5E (0.53) | NT5EPTPN1CDC25BPTPN2PTPN11 | |
| SCHEMBL976473 | 0.89 | NT5E (0.51) | NT5EPTPN1CDC25BPTPN2PTPN11 | |
| SCHEMBL976471 | 0.89 | NT5E (0.51) | NT5EPTPN1CDC25BPTPN2PTPN11 | |
| SCHEMBL9145474 | 0.87 | SSTR1 (0.47) | NT5EPTPN1CDC25BPTPN2PTPN11 | |
| SCHEMBL9149771 | 0.83 | NT5E (0.43) | NT5EPTPN1CDC25BPTPN2PTPN11 | |
| SCHEMBL24696311 | 0.83 | NT5E (0.47) | NT5EPTPN1CDC25BPTPN2PTPN11 | |
| SCHEMBL23603977 | 0.83 | NT5E (0.47) | NT5EPTPN1CDC25BPTPN2PTPN11 | |
| SCHEMBL23603383 | 0.83 | NT5E (0.47) | NT5EPTPN1CDC25BPTPN2PTPN11 | |
| SCHEMBL23603950 | 0.83 | NT5E (0.47) | NT5EPTPN1CDC25BPTPN2PTPN11 | |
| SCHEMBL23603952 | 0.83 | NT5E (0.47) | NT5EPTPN1CDC25BPTPN2PTPN11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5474986-A | Galabiose derivatives modified at 3* and anomeric positions | SYMBICOM AKTIEBOLAG (SE) | 1995-12-12 | — | — | US | disclosed |
| EP-0428605-B1 | SYNTHETIC RECEPTOR ANALOGUES | SYMBICOM AB (SE) | 1994-10-19 | — | — | EP | disclosed |